Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Brandon Mcmahon

Concepts (228)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thrombosis
5
2015
298
1.390
Why?
Myeloproliferative Disorders
8
2022
26
1.320
Why?
Urokinase-Type Plasminogen Activator
4
2015
28
1.060
Why?
Plasminogen Activator Inhibitor 1
3
2015
83
0.950
Why?
Neoplasms
8
2020
2097
0.940
Why?
Thrombocytopenia
3
2016
177
0.940
Why?
Hemorrhage
5
2018
620
0.880
Why?
Anticoagulants
4
2018
550
0.880
Why?
Plasminogen
3
2013
33
0.750
Why?
Fibrinolysin
2
2013
15
0.740
Why?
Receptors, Urokinase Plasminogen Activator
2
2015
10
0.570
Why?
Anemia, Pernicious
1
2016
9
0.530
Why?
Pancytopenia
1
2016
7
0.530
Why?
Neoplasm Proteins
2
2009
385
0.510
Why?
Hypothyroidism
1
2016
64
0.510
Why?
Myelodysplastic Syndromes
2
2016
119
0.500
Why?
Unnecessary Procedures
1
2014
44
0.450
Why?
Heparin
1
2014
224
0.420
Why?
Tissue Inhibitor of Metalloproteinase-2
1
2013
12
0.420
Why?
Liver Cirrhosis
1
2014
227
0.410
Why?
Enzyme-Linked Immunosorbent Assay
1
2014
797
0.400
Why?
Thrombophilia
2
2009
67
0.380
Why?
Blood Platelets
1
2014
351
0.380
Why?
Polycythemia Vera
4
2022
12
0.370
Why?
Fibrinolysis
2
2009
158
0.350
Why?
Medical Oncology
4
2022
229
0.340
Why?
Biomarkers, Tumor
2
2018
1040
0.340
Why?
Interferon Type I
3
2015
128
0.320
Why?
Antineoplastic Agents
5
2018
1879
0.300
Why?
Tissue Plasminogen Activator
2
2009
225
0.290
Why?
Intracellular Signaling Peptides and Proteins
3
2015
388
0.280
Why?
Primary Myelofibrosis
2
2022
9
0.230
Why?
Thrombocythemia, Essential
1
2022
6
0.210
Why?
Interferon-alpha
2
2014
186
0.200
Why?
Humans
31
2022
114696
0.200
Why?
MAP Kinase Signaling System
2
2015
276
0.200
Why?
Mastocytosis, Systemic
1
2018
6
0.160
Why?
Eosinophilia
1
2020
186
0.150
Why?
Chicago
2
2016
45
0.150
Why?
Risk Factors
4
2015
8632
0.140
Why?
Neovascularization, Pathologic
2
2009
281
0.140
Why?
Neoplasm Metastasis
2
2009
523
0.140
Why?
Janus Kinase 2
2
2015
31
0.140
Why?
Anaphylaxis
1
2018
143
0.130
Why?
Philadelphia Chromosome
1
2016
15
0.130
Why?
Vitamin B 12 Deficiency
1
2016
74
0.130
Why?
Anemia, Iron-Deficiency
1
2016
53
0.120
Why?
Age Factors
4
2015
2894
0.120
Why?
Vitamin B 12
1
2016
115
0.120
Why?
Fusion Proteins, bcr-abl
1
2015
61
0.120
Why?
Thienamycins
1
2015
4
0.120
Why?
Biomarkers
2
2016
3408
0.120
Why?
Piperacillin
1
2015
8
0.120
Why?
Inactivation, Metabolic
1
2015
11
0.120
Why?
Venous Thromboembolism
1
2018
231
0.120
Why?
Anemia, Hemolytic
1
2015
18
0.120
Why?
Vitamin K
1
2015
42
0.120
Why?
Cell Movement
2
2009
869
0.120
Why?
Signal Transduction
4
2016
4515
0.120
Why?
False Positive Reactions
1
2014
109
0.120
Why?
Hemostasis
1
2014
67
0.110
Why?
Patient Care Team
1
2018
517
0.110
Why?
Pyrazoles
2
2016
362
0.110
Why?
Drug Hypersensitivity
1
2015
83
0.110
Why?
Drug Monitoring
1
2015
184
0.110
Why?
Bone Marrow Neoplasms
1
2013
3
0.110
Why?
Academic Medical Centers
1
2016
411
0.110
Why?
Blood Transfusion
1
2016
293
0.110
Why?
Pseudomonas Infections
1
2015
184
0.110
Why?
Chi-Square Distribution
1
2014
493
0.110
Why?
Thrombocytosis
1
2012
6
0.110
Why?
Interferon-beta
1
2013
79
0.110
Why?
Leukocytosis
1
2012
34
0.100
Why?
Predictive Value of Tests
2
2015
1796
0.100
Why?
Receptor, Interferon alpha-beta
1
2012
23
0.100
Why?
Administration, Oral
1
2015
728
0.100
Why?
Prognosis
3
2016
3329
0.100
Why?
Antibodies
1
2014
371
0.100
Why?
Annexin A2
2
2009
10
0.100
Why?
Adult
8
2022
30552
0.100
Why?
Kaplan-Meier Estimate
1
2014
811
0.100
Why?
Nitriles
1
2012
149
0.100
Why?
Gene Expression Regulation, Neoplastic
2
2015
1141
0.100
Why?
RNA-Binding Proteins
1
2014
345
0.090
Why?
Respiratory Tract Infections
1
2015
319
0.090
Why?
Phosphoproteins
1
2012
298
0.090
Why?
Leukemia, Myeloid, Acute
1
2016
534
0.090
Why?
Nuclear Proteins
1
2014
591
0.090
Why?
Apoptosis
2
2009
2363
0.080
Why?
Carrier Proteins
1
2014
695
0.080
Why?
Pyrimidines
1
2012
376
0.080
Why?
Disease Progression
3
2015
2380
0.080
Why?
Mutation
3
2018
3346
0.080
Why?
Leukemia, Promyelocytic, Acute
1
2009
12
0.080
Why?
Cryoglobulins
1
2009
6
0.080
Why?
Carboxypeptidase B2
1
2009
4
0.080
Why?
Plasminogen Inactivators
1
2009
3
0.080
Why?
Receptors, Peptide
1
2009
18
0.080
Why?
Anemia, Hemolytic, Autoimmune
1
2009
11
0.080
Why?
Blood Group Antigens
1
2009
14
0.080
Why?
Cerebral Infarction
1
2009
39
0.080
Why?
Nerve Tissue Proteins
1
2012
529
0.080
Why?
Edetic Acid
1
2008
47
0.080
Why?
Factor VII
1
2008
26
0.080
Why?
Factor VIII
1
2008
53
0.080
Why?
von Willebrand Factor
1
2008
56
0.080
Why?
Time Factors
2
2018
6116
0.080
Why?
Animals
7
2016
31708
0.070
Why?
Multiple Organ Failure
1
2009
146
0.070
Why?
Transcription, Genetic
1
2014
1313
0.070
Why?
Oncogene Proteins, Fusion
2
2020
179
0.070
Why?
Practice Patterns, Physicians'
1
2016
1177
0.070
Why?
Immunoglobulin M
1
2009
246
0.070
Why?
Neoplasm Invasiveness
1
2009
442
0.070
Why?
Intercellular Signaling Peptides and Proteins
1
2009
351
0.070
Why?
Cell Division
1
2009
758
0.070
Why?
Membrane Proteins
1
2012
1019
0.070
Why?
Blood Coagulation Disorders
1
2009
197
0.070
Why?
Retrospective Studies
4
2016
12554
0.070
Why?
Ischemia
1
2009
362
0.060
Why?
Cytokines
2
2014
1841
0.060
Why?
Anti-Bacterial Agents
1
2015
1481
0.060
Why?
Intestines
1
2009
326
0.060
Why?
Female
7
2016
59518
0.060
Why?
Cystic Fibrosis
1
2015
955
0.060
Why?
Mice
5
2014
14871
0.060
Why?
Societies, Medical
2
2018
664
0.060
Why?
Immunosuppressive Agents
1
2009
646
0.060
Why?
Aged
4
2016
19074
0.060
Why?
Janus Kinases
2
2016
12
0.060
Why?
Aging
1
2014
1618
0.060
Why?
Molecular Targeted Therapy
2
2018
347
0.060
Why?
Erythroid Cells
2
2015
7
0.060
Why?
Treatment Outcome
4
2018
9088
0.060
Why?
Middle Aged
5
2016
26737
0.060
Why?
p38 Mitogen-Activated Protein Kinases
2
2015
260
0.050
Why?
Antibodies, Monoclonal
1
2009
1262
0.050
Why?
Survival Analysis
2
2018
1211
0.050
Why?
Autoantibodies
1
2009
1346
0.050
Why?
Combined Modality Therapy
2
2017
1121
0.050
Why?
Hematopoietic Stem Cells
2
2014
343
0.040
Why?
Male
6
2016
55604
0.040
Why?
Phosphorylation
2
2014
1569
0.040
Why?
mRNA Cleavage and Polyadenylation Factors
1
2018
26
0.040
Why?
Histamine Antagonists
1
2018
20
0.040
Why?
Fibroblasts
2
2014
838
0.040
Why?
Receptor, Platelet-Derived Growth Factor alpha
1
2018
40
0.040
Why?
Proto-Oncogene Proteins c-kit
1
2018
63
0.040
Why?
Prevalence
2
2015
2251
0.040
Why?
Cell Line, Tumor
2
2015
2710
0.040
Why?
Mast Cells
1
2018
116
0.040
Why?
Immunophenotyping
1
2018
274
0.040
Why?
Transplantation, Homologous
1
2018
377
0.040
Why?
Bone Marrow
1
2018
243
0.040
Why?
Cells, Cultured
2
2015
3886
0.030
Why?
Receptors, Thrombopoietin
1
2016
5
0.030
Why?
Thrombopoietin
1
2016
4
0.030
Why?
Drug Administration Schedule
1
2018
718
0.030
Why?
Hydrazines
1
2016
28
0.030
Why?
Benzoates
1
2016
38
0.030
Why?
Receptors, Fc
1
2016
45
0.030
Why?
Antimetabolites, Antineoplastic
1
2016
81
0.030
Why?
General Practice
1
2016
27
0.030
Why?
Drug Therapy, Combination
1
2018
951
0.030
Why?
Platelet Count
1
2015
81
0.030
Why?
Autophagy-Related Protein-1 Homolog
1
2015
6
0.030
Why?
Azacitidine
1
2016
129
0.030
Why?
Immunologic Tests
1
2015
16
0.030
Why?
Biopsy
1
2018
1036
0.030
Why?
Aged, 80 and over
2
2016
6347
0.030
Why?
Interferon Regulatory Factors
1
2015
29
0.030
Why?
Patient Selection
1
2018
641
0.030
Why?
Interferons
1
2016
151
0.030
Why?
Response Elements
1
2015
82
0.030
Why?
Nuclear Cap-Binding Protein Complex
1
2014
1
0.030
Why?
Ubiquitins
1
2014
31
0.030
Why?
Ribosomal Protein S6 Kinases, 90-kDa
1
2014
13
0.030
Why?
Dose-Response Relationship, Drug
1
2018
1842
0.030
Why?
Guanosine
1
2014
39
0.030
Why?
Rapamycin-Insensitive Companion of mTOR Protein
1
2014
28
0.030
Why?
Health Care Surveys
1
2016
539
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2014
107
0.030
Why?
Medication Adherence
1
2018
536
0.030
Why?
Microbial Sensitivity Tests
1
2015
300
0.030
Why?
Risk
1
2016
812
0.030
Why?
Mutation, Missense
1
2015
293
0.030
Why?
Recombinant Fusion Proteins
1
2016
616
0.030
Why?
Eukaryotic Initiation Factor-4E
1
2013
27
0.030
Why?
Hematopoietic Stem Cell Transplantation
1
2018
520
0.030
Why?
Randomized Controlled Trials as Topic
1
2018
1214
0.030
Why?
Cell Line, Transformed
1
2013
133
0.030
Why?
Aspirin
1
2015
324
0.030
Why?
Hospitalists
1
2016
174
0.030
Why?
U937 Cells
1
2012
22
0.030
Why?
Gene Knockdown Techniques
1
2014
301
0.030
Why?
Multivariate Analysis
1
2016
1430
0.030
Why?
Embryo, Mammalian
1
2012
213
0.020
Why?
Epigenesis, Genetic
1
2016
520
0.020
Why?
Patient Outcome Assessment
1
2013
122
0.020
Why?
Logistic Models
1
2016
1841
0.020
Why?
Leukemia
1
2013
209
0.020
Why?
Protein Kinase Inhibitors
1
2016
785
0.020
Why?
Vascular Diseases
1
2013
230
0.020
Why?
Adaptor Proteins, Signal Transducing
1
2012
367
0.020
Why?
Splanchnic Circulation
1
2009
12
0.020
Why?
Infarction
1
2009
12
0.020
Why?
Plasmapheresis
1
2009
22
0.020
Why?
Blood Specimen Collection
1
2008
31
0.020
Why?
Antibody Specificity
1
2009
176
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2009
82
0.020
Why?
Risk Assessment
1
2017
2968
0.020
Why?
Giant Cell Arteritis
1
2009
48
0.020
Why?
Immunoassay
1
2008
95
0.020
Why?
Tretinoin
1
2009
122
0.020
Why?
Fatal Outcome
1
2009
284
0.020
Why?
Rituximab
1
2009
150
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2016
1355
0.020
Why?
Hospitalization
1
2016
1752
0.020
Why?
Spleen
1
2009
487
0.020
Why?
Plasma
1
2008
211
0.020
Why?
Internship and Residency
1
2016
926
0.020
Why?
Mice, Knockout
1
2012
2570
0.020
Why?
Cell Differentiation
1
2013
1701
0.020
Why?
Cross-Sectional Studies
1
2016
4410
0.020
Why?
United States
1
2018
12185
0.010
Why?
Kidney
1
2009
1188
0.010
Why?
Liver
1
2009
1637
0.010
Why?
Adolescent
1
2015
17853
0.010
Why?
Mcmahon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)